Belarus Pharmaceuticals and Healthcare Report Q3 2015

86 PagesBMI ResearchJune 10, 2015
SKU: BMI5586469

Belarus Pharmaceuticals and Healthcare Report Q3 2015

BMI View: Collapsing external trade will have a highly damaging impact on living standards in Belarus,impacting incomes, employment and consumer sentiment, and we expect the pharmaceutical sector to behurt by these factors. We expect the Belarusian government to increase its focus on import substitutiongiven its balance of payments crisis, with negative implications for the pharmaceutical sector.

Headline Expenditure Projections

Pharmaceuticals: BYR10,223bn in 2014 (USD998mn) to BYR12,355bn (USD887mn) in 2015; +20.9% inlocal currency terms and -11.1% in US dollar terms.

Healthcare: BYR47,583bn (USD4.64bn) in 2014 to BYR60,068bn (USD4.31bn) in 2015; +26.2% in localcurrency terms and -7.1% in US dollar terms.